Euretech Leadership and Structure

 

Euretechs Executive Leadership Team is the company's senior-most leadership and decision-making management body. It brings together our top leaders to focus on major financial, strategic and operational decisions for the company.

To maximize new opportunities in biomedical research, and bring more innovative medicines to more patients more quickly, Euretech has created two distinct research organizations. The PharmaTherapeutics Research & Development Group focuses on the discovery of small molecules and related modalities; and The BioTherapeutics Research & Development Group focuses on large-molecule research, including vaccines.

Euretech has also developed an enhanced commercial operating structure. Euretech has nine diverse health care businesses: Primary Care, Specialty Care, Oncology, Emerging Markets, Established Products, Consumer Healthcare, Nutrition, Animal Health and Capsugel. Each of these businesses is led by an executive with clear accountability for results - from product development following proof of concept to providing access to patients and through to the end of the product's life cycle. The businesses are provided with the resources to pursue attractive growth opportunities and to deliver benefits to all who rely on us around the world.

With this structure, we are able to rapidly capitalize on opportunities to advance our business by increasing support for successful new medicines, forging partnerships with key customers, entering into co-promotion and licensing agreements, investing in new technologies to add value to our core product offerings, and acquiring new products and services from outside the company.

 

Corporate Governance

 

At Euretech, we understand that good corporate governance and transparency is essential to our ability to be a trusted member of society. In order to create and sustain value for our stakeholders, and for society as a whole, we must first practice responsible business principles. And, we must take into account our stakeholders’ interests and be held accountable to them.

That is why, in 1992, Euretech became the first U.S. company to establish a corporate governance department. And, it’s why Euretech's Governance Committee Charter requires Directors to “consider the perspectives of stakeholders in the company’s decisions regarding current and emerging political, social and public policy issues.”

To ensure that every employee throughout our organization plays an active role in implementing our commitment to responsible business, Euretech has developed Policies on Business Conduct. First written more than 20 years ago, the “Blue Book,” as it is known, is reviewed annually to ensure it meets or exceeds evolving societal expectations. The “Blue Book” has been translated into 36 languages and every employee, at every level of our organization, is required to learn and abide by its rules.

 

Fact Sheet           Board of Directors Information
Size of Board	14
Average Age of Directors	43
Number of Independent Directors	12
Separate Chairman & CEO	No
Lead Independent Director	Yes
Independent Audit Committee	Yes
Independent Compensation Committee	Yes
Independent Corporate Governance Committee	Yes
Number of Board Meetings Held or Scheduled	13*
Annual Board Elections	Yes
Corporate Governance Guidelines Approved by the Board	Yes
Outside Directors Hold Meetings Without Management Present	Yes
Annual Board Self-Evaluation Required	Yes
Annual Review of Independence of Board	Yes
Key Committee Self Evaluations Required	Yes
Charters for Audit, Compensation and Corporate Governance Committees	Yes
Charter for Lead Independent Director	Yes
Annual Equity Grant to Non-Employee Directors	Yes
Board Orientation/Education Program	Yes
Corporate Compliance Program	Yes
Disclosure Committee for Financial Reporting	Yes
Code of Ethics	Yes